Nomura Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Sell
48,123
-724
-1% -$142K 0.02% 460
2026
Q1
$9.57M Buy
48,847
+409
+0.8% +$79.5K 0.02% 450
2025
Q4
$8.41M Sell
48,438
-210
-0.4% -$38.2K 0.02% 481
2025
Q3
$9.27M Buy
48,648
+2,392
+5% +$424K 0.02% 454
2025
Q2
$8.31M Sell
46,256
-934
-2% -$162K 0.02% 482
2025
Q1
$7.98M Buy
47,190
+3,594
+8% +$590K 0.02% 473
2024
Q4
$6.58M Sell
43,596
-1,229
-3% -$191K 0.02% 508
2024
Q3
$6.96M Sell
44,825
-2,069
-4% -$309K 0.02% 494
2024
Q2
$6.42M Sell
46,894
-23,971
-34% -$3.28M 0.02% 490
2024
Q1
$9.43M Buy
70,865
+802
+1% +$104K 0.03% 395
2023
Q4
$9.66M Buy
70,063
+3,023
+5% +$397K 0.04% 379
2023
Q3
$8.17M Buy
67,040
+9,269
+16% +$1.23M 0.04% 391
2023
Q2
$8.12M Buy
57,771
+5,406
+10% +$745K 0.04% 395
2023
Q1
$7.41M Sell
52,365
-1,691
-3% -$242K 0.04% 398
2022
Q4
$8.46M Sell
54,056
-37,599
-41% -$5.4M 0.05% 353
2022
Q3
$11.2M Buy
91,655
+2,840
+3% +$374K 0.07% 286
2022
Q2
$11.8M Buy
88,815
+60,828
+217% +$8.29M 0.07% 277
2022
Q1
$3.83M Buy
27,987
+1,359
+5% +$189K 0.02% 556
2021
Q4
$4.61M Sell
26,628
-770
-3% -$117K 0.02% 513
2021
Q3
$3.98M Buy
27,398
+479
+2% +$70.1K 0.02% 533
2021
Q2
$3.55M Buy
26,919
+1,786
+7% +$234K 0.02% 574
2021
Q1
$3.23M Buy
25,133
+198
+0.8% +$24.4K 0.02% 573
2020
Q4
$2.97M Buy
24,935
+1,650
+7% +$201K 0.02% 568
2020
Q3
$2.67M Sell
23,285
-3,491
-13% -$412K 0.02% 529
2020
Q2
$3.05M Sell
26,776
-2,599
-9% -$276K 0.03% 460
2020
Q1
$2.36M Buy
29,375
+1,570
+6% +$163K 0.02% 465
2019
Q4
$2.97M Sell
27,805
-160
-0.6% -$16.7K 0.03% 484
2019
Q3
$2.99M Sell
27,965
-41
-0.1% -$4.21K 0.03% 459
2019
Q2
$2.85M Sell
28,006
-59
-0.2% -$5.67K 0.03% 461
2019
Q1
$2.52M Buy
28,065
+4,799
+21% +$416K 0.02% 490
2018
Q4
$1.94M Buy
23,266
+1,276
+6% +$120K 0.02% 514
2018
Q3
$2.37M Sell
21,990
-30
-0.1% -$3.29K 0.02% 499
2018
Q2
$2.42M Buy
22,020
+1,091
+5% +$114K 0.03% 489
2018
Q1
$2.1M Buy
20,929
+76
+0.4% +$7.78K 0.02% 523
2017
Q4
$2.05M Buy
20,853
+1,075
+5% +$102K 0.02% 505
2017
Q3
$1.85M Buy
19,778
+299
+2% +$31.7K 0.02% 503
2017
Q2
$2.17M Sell
19,479
-101
-0.5% -$10.7K 0.03% 439
2017
Q1
$1.92M Buy
19,580
+1,627
+9% +$155K 0.03% 479
2016
Q4
$1.65M Sell
17,953
-500
-3% -$43.1K 0.03% 486
2016
Q3
$1.56M Hold
18,453
0.03% 498
2016
Q2
$1.5M Buy
18,453
+300
+2% +$22.8K 0.03% 484
2016
Q1
$1.3M Buy
18,153
+410
+2% +$27.5K 0.02% 536
2015
Q4
$1.26M Hold
17,743
0.02% 525
2015
Q3
$1.09M Buy
17,743
+413
+2% +$28.9K 0.02% 561
2015
Q2
$1.26M Sell
17,330
-500
-3% -$36.9K 0.02% 527
2015
Q1
$1.37M Sell
17,830
-3,310
-16% -$237K 0.02% 508
2014
Q4
$1.44M Sell
21,140
-200
-0.9% -$12.6K 0.03% 477
2014
Q3
$1.29M Buy
21,340
+2,100
+11% +$129K 0.02% 490
2014
Q2
$1.13M Sell
19,240
-920
-5% -$53.9K 0.02% 538
2014
Q1
$1.17M Sell
20,160
-290
-1% -$15.5K 0.02% 511
2013
Q4
$1.09M Sell
20,450
-1,820
-8% -$108K 0.02% 528
2013
Q3
$1.38M Sell
22,270
-5,127
-19% -$307K 0.03% 465
2013
Q2
$1.66M Buy
+27,397
New +$1.63M 0.03% 443

Other funds holding DGX

Nomura Asset Management's DGX Position: Q2 2026 in Review

Nomura Asset Management reduced its Quest Diagnostics (DGX) stake by 1.5% in Q2 2026, selling an estimated $142K and leaving 48,123 shares worth $10.2M. The position accounts for 0.02% of the portfolio, ranked #460.

Nomura Asset Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.8M in Q2 2022. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Nomura Asset Management held 48,123 shares of Quest Diagnostics worth $10.2M as of Q2 2026.
  • Nomura Asset Management sold 724 Quest Diagnostics shares in Q2 2026, an estimated $142K.
  • Quest Diagnostics made up 0.02% of Nomura Asset Management's portfolio in Q2 2026, its #460 holding.
  • Nomura Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • Nomura Asset Management's Quest Diagnostics position peaked at $11.8M in Q2 2022.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.